Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Most rejections for a GLP-1 prescription under a military or VA benefit trace to one of five mechanisms: the drug sits in a category the benefit treats differently, the documented condition falls outside what the benefit pays for, a required authorization was never filed, the quantity or pharmacy channel breaks a rule, or the person’s eligibility record is out of date. Each has a different fix.
A pharmacy counter message is not a coverage decision. It is a claim adjudication result, and the two get confused constantly. A message saying a drug needs authorization means no clinical review happened yet. A message saying the drug is excluded means the review would not matter. These require completely different responses, and calling a benefit line without the actual reject text produces a conversation that goes nowhere.
Working out which mechanism applies is easier with a plain-language reference open. A number of telehealth companies now publish coverage explainers alongside their own services. Henry Meds, Ro and Hims and Hers each describe how plans tend to handle these prescriptions, and HealthRX keeps a page on GLP-1 insurance coverage laying out prior authorization and appeal steps in order. Material like that is worth reading for the terminology before a call, provided the plan’s own criteria document stays the final word.
The TRICARE pharmacy benefit places drugs into generic formulary, brand-name formulary, non-formulary and non-covered categories. Non-formulary status is not refusal. It means a higher cost share, and if a prescriber establishes medical necessity the drug moves to the formulary cost share, or to no cost for active duty service members. Some non-formulary products are only dispensed through home delivery, which produces a rejection at a retail counter that reads like a denial and is really a channel restriction.
On the VA side the equivalent structure is the VA National Formulary, maintained by Pharmacy Benefits Management Services and searchable through the VA Formulary Advisor tool. An agent absent from the national list can still be requested through the non-formulary process, which a prescriber submits and a facility reviews.
Benefits exclude drugs prescribed for conditions the benefit does not cover, and that exclusion operates independently of what tier a drug sits in. This is the mechanism most likely to sink a weight-management request quietly, because the drug itself may be perfectly well covered for a different indication. Where a claim was submitted with a diagnosis that does not match the prescribing rationale, the correction is documentation in the chart rather than an argument about the drug.
Guideline bodies have argued that obesity should be diagnosed on more than a single index value, and current pharmacotherapy guidance frames these agents as treatment for a chronic condition. Utilization rules move more slowly than guidelines do, so what governs the claim is the criteria document in force, not the most recent consensus statement.
Under the TRICARE pharmacy program, prior authorization applies when a drug is specified by the Department of Defense Pharmacy and Therapeutics Committee, when a brand-name product has a generic substitute, when age limits apply, or when the quantity exceeds the normal limit. The form is downloaded from the formulary search tool, completed by the prescriber and returned to the pharmacy contractor. Patients cannot file it. A striking share of rejections happen because everyone assumed someone else had sent the form.
Day-supply limits differ by pharmacy type. Military pharmacies and home delivery support up to a 90-day supply, while a retail network pharmacy supports up to 30 days, with exceptions available where a prescriber establishes medical necessity. A prescription written for 90 days and presented at a retail counter rejects on quantity, not on coverage. Filling at a non-network pharmacy means paying up front and claiming reimbursement afterward, subject to deductible and out-of-network cost shares.
Enrollment data drives adjudication. If the Defense Enrollment Eligibility Reporting System record is stale after a move, a separation, a marriage or a child aging out, claims reject on eligibility while everything clinical is in order. Veterans hit a parallel version of this when enrollment status or priority group information is out of date, or when a prescription originates with a community provider and was never converted into the VA system.
| What the counter says | Usual mechanism | Who has to act | Realistic timeline |
|---|---|---|---|
| Prior authorization required | No clinical review filed | Prescribing office | Days once the form goes in |
| Drug not covered | Non-covered category or excluded condition | Prescriber, or a change of agent | Weeks, sometimes not at all |
| Higher cost than expected | Non-formulary cost share | Prescriber files medical necessity | Days to weeks |
| Quantity exceeds limit | Day supply wrong for that channel | Pharmacy, or a rewritten script | Same day |
| Not eligible | Enrollment record out of date | Beneficiary updates the record | Days |
| Fill at home delivery only | Channel restriction on that product | Beneficiary switches channel | One to two weeks |
Sorting a rejection takes time, and treatment interruption has a cost of its own. Some people price a self-pay route in parallel so the decision is between two known numbers rather than one number and a wait. Cash telehealth practices such as formblends.com publish a monthly figure for supervised treatment with a compounded preparation, and the honest comparison has to account for the fact that compounded products are not FDA-approved and carry none of the trial evidence generated by the branded agents. Manufacturer self-pay pharmacies are the other reference point, since they sell approved products at a published price.
A prescription written by a clinician outside the system a beneficiary is using creates its own category of problem. Veterans who receive a prescription during community care may find it needs to be reissued or reviewed before a VA pharmacy fills it. Military beneficiaries with other health insurance run into coordination rules, where the other plan pays first and the military benefit acts as second payer. Neither is a clinical judgment about the drug.
Does a rejection mean the drug will never be paid for?
Usually not. Most rejections are procedural, meaning a form is missing, a quantity is wrong or a record is stale. Only the non-covered category and an excluded condition are substantive refusals, and even those can shift when formulary categories are revisited on the regular review cycle.
Can a beneficiary file the authorization themselves?
No. Authorization and medical necessity submissions come from the prescriber, because they rest on clinical documentation. What a beneficiary can contribute is missing material the office lacks, such as a dated weight history, records from a previous clinician, or evidence of an earlier medication trial.
Why do two people with the same benefit get different answers?
Beneficiary category, plan, group and pharmacy channel all feed into the result. Active duty service members, retirees, family members and enrolled veterans are governed by different rules and different cost structures, so one person’s experience is a weak predictor of another’s.
Is an appeal worth filing after a rejection?
It depends on the mechanism. A missing form is fixed by sending the form, not by appealing. An appeal is the right instrument when a medical necessity request or authorization was reviewed and refused, and both systems set deadlines for filing, so the clock starts at the decision date.